Characteristics of cluster randomized trials: Are they living up to the randomized trial?

JAMA Internal Medicine

Volumn 173, Issue 4, 2013, Pages 313-315

  Selvaraj, Senthil ^a   Prasad, Vinay ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE;

AMBIVALENCE; BACTERIAL COLONIZATION; CANCER PREVENTION; CARDIOVASCULAR RISK; CHI SQUARE TEST; FISHER EXACT TEST; HEALTH PROGRAM; HORMONAL THERAPY; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANK SUM TEST;

BIBLIOMETRICS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84874910442     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.1638     Document Type: Letter

References (5)

1. Campbell MK, Elbourne DR, Altman DG; CONSORT group. CONSORT statement: extension to cluster randomised trials. BMJ. 2004;328 (7441): 702-708.
2. Bland JM. Cluster randomised trials in the medical literature: two bibliometric surveys. BMC Med Res Methodol. 2004;4:21.
3. Platt R. Time for a culture change? N Engl J Med. 2011;364 (15): 1464-1465.
4. Jain R, Kralovic SM, Evans ME, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med. 2011; 364 (15): 1419-1430.
5. Huskins WC, Huckabee CM, O'Grady NP, et al; STAR*ICU Trial Investigators. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011;364 (15): 1407-1418.